Relationship between hemodynamic changes and endogenous catecholamine release caused by a new antiarrhythmic agent, AB-2, in cats and dogs.

M Filczewski; K Oledzka; M Szymańska-Kosmala

PubMed · 7187044

Relationship between hemodynamic changes and endogenous catecholamine release caused by a new antiarrhythmic agent, AB-2, in cats and dogs.

M Filczewski·K Oledzka·M Szymańska-Kosmala

Abstract

An antiarrhythmic agent, AB-2, given iv produced in cats and dogs a biphasic action on blood pressure: rapid and short-lasting hypertension followed by depression of blood pressure. The first phase was accompanied by a sharp rise of serum catecholamines (6-fold increase in adrenaline, and 4.5-fold increase in noradrenaline level) and of indices of left ventricular contractility. These effects were more pronounced in cats than in dogs. In cats, but not dogs, the biphasic effect was observed also after po administration. The elevated endogenous catecholamine release was not accompanied by an increase in plasma 11-hydroxycorticosteroids levels.

Explore related subjects

11-Hydroxycorticosteroids Animals Blood Pressure Catecholamines Cats Dogs Epinephrine Heart Rate Hemodynamics Male Norepinephrine Quinidine Quinuclidines Species Specificity Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

M Filczewski, K Oledzka, M Szymańska-Kosmala. Relationship between hemodynamic changes and endogenous catecholamine release caused by a new antiarrhythmic agent, AB-2, in cats and dogs.. https://pubmed.ncbi.nlm.nih.gov/7187044/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Comparison of different enzyme-immunoassays for assessment of adrenocortical activity in primates based on fecal analysis.

Most studies published to date that used fecal glucocorticoid measurements to assess adrenocortical activity in primate (and many nonprimate) species applied a specific cortisol or corticosterone assay. However, since these native glucocorticoids are virtually absent in the feces of most vertebrates, including primates, the validity of this approach has recently been questioned. Therefore, the overall aim of the present study was to assess the validity of four enzyme-immunoassays (EIAs) using antibodies raised against cortisol, corticosterone, and reduced cortisol metabolites (two group-specific antibodies) for assessing adrenocortical activity using fecal glucocorticoid metabolite (GCM) measurements in selected primate species (marmoset, long-tailed macaque, Barbary macaque, chimpanzee, and gorilla). Using physiological stimulation of the hypothalamo-pituitary-adrenocortical (HPA) axis by administering exogenous ACTH or anesthesia, we demonstrated that at least two assays detected the predicted increase in fecal GCM levels in response to treatment in each species. However, the magnitude of response varied between assays and species, and no one assay was applicable to all species. While the corticosterone assay generally was of only limited suitability for assessing glucocorticoid output, the specific cortisol assay was valuable for those species that (according to high-performance liquid chromatography (HPLC) analysis data) excreted clearly detectable amounts of authentic cortisol into the feces. In contrast, in species in which cortisol was virtually absent in the feces, group-specific assays provided a much stronger signal, and these assays also performed well in the other primate species tested (except the marmoset). Collectively, the data suggest that the reliability of a given fecal glucocorticoid assay in reflecting activity of the HPA axis in primates clearly depends on the species in question. Although to date there is no single assay system that can be used successfully across species, our data suggest that group-specific assays have a high potential for cross-species application. Nevertheless, regardless of which GC antibody is chosen, our study clearly reinforces the necessity of appropriately validating the respective assay system before it is used.

11-Hydroxycorticosteroids↗

PubMed2006

[Optimization of hepatoprotective therapy of viral hepatitis with consideration of neuromediatory link of pathogenesis].

AIM: To study therapeutic efficacy of hepatoprotective modalities on the experimental hepatitis model and in patients with parenteral hepatitis B and C regarding neurogenic amines and their coefficients. MATERIAL AND METHODS: 38 hepatoprotectors were screened for the highest activity in 1000 white rats with toxic hepatitis. Blood catecholamines (CA), histamine (H), serotonin (S), 11-oxycorticosteroids (11-OCS) were studied in 100 patients with acute hepatitis B and C. RESULTS: The recommended hepatoprotectors optimized treatment of hepatitis, led to rapid correction of abdominal and dyspeptic syndromes, normalization of bilirubin, alkaline phosphatase, cytolysis enzymes levels, improvement of neuromediatory balance. Six-month follow-up demonstrated improvement of biochemical indices in patients given hepatoprotectors with a confirmed action. CONCLUSION: Hepatoprotectors are necessary in pathogenetic treatment of acute hepatitis B and C.

11-Hydroxycorticosteroids↗

PubMed2005

The excretion rates of stress hormones under mental work.

The aim of the study was to assess stress on the basis of the excretion rates of stress hormones in occupational groups under mental stress. The investigation includes 293 persons, working in power engineering, education, public health and information sector. The stress hormones adrenaline, noradrenaline and 11-oxycorticosteroids (11-OCS) were followed during the working day using spectrofluorimetric methods. Very high excretion rates of adrenaline, noradrenaline and/or 11-OCS were found with leading radio editors, responsible engineers and operators in nuclear power station (NPS), teachers in secondary schools, designing engineers. In conclusion our data indicate high stress in occupational groups working under high psychological demands, high responsibility, making important managing decisions, low job control and are discussed with regard to the health risk.

11-Hydroxycorticosteroids↗